These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 33616160)

  • 1. "We Need to Taper." Interviews with Clinicians and Pharmacists About Use of a Pharmacy-Led Opioid Tapering Program.
    Firemark AJ; Schneider JL; Kuntz JL; Papajorgji-Taylor D; Dickerson JF; Thorsness LA; Reese KR; Sullivan MD; Debar LL; Smith DH
    Pain Med; 2021 May; 22(5):1213-1222. PubMed ID: 33616160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Pharmacist-Led Program to Taper Opioid Use at Kaiser Permanente Northwest: Rationale, Design, and Evaluation.
    Kuntz JL; Schneider JL; Firemark AJ; Dickerson JF; Papajorgji-Taylor D; Reese KR; Hamer TA; Marsh D; Thorsness LA; Sullivan MD; Debar LL; Smith DH
    Perm J; 2020; 24():. PubMed ID: 33196429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "I really had somebody in my corner." Patient experiences with a pharmacist-led opioid tapering program.
    Schneider JL; Firemark AJ; Papajorgji-Taylor D; Reese KR; Thorsness LA; Sullivan MD; DeBar LL; Smith DH; Kuntz JL
    J Am Pharm Assoc (2003); 2023; 63(1):241-251.e1. PubMed ID: 35718714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expanding the role of clinical pharmacists on interdisciplinary primary care teams for chronic pain and opioid management.
    Giannitrapani KF; Glassman PA; Vang D; McKelvey JC; Thomas Day R; Dobscha SK; Lorenz KA
    BMC Fam Pract; 2018 Jul; 19(1):107. PubMed ID: 29970008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The opioid renewal clinic: a primary care, managed approach to opioid therapy in chronic pain patients at risk for substance abuse.
    Wiedemer NL; Harden PS; Arndt IO; Gallagher RM
    Pain Med; 2007; 8(7):573-84. PubMed ID: 17883742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Survey on Opioid Tapering Practices, Policies, and Perspectives by Pain and Palliative Care Pharmacists.
    Kral LA; Bettinger JJ; Vartan CM; Hadlandsmyth K; Kullgren J; Smith MA
    J Pain Palliat Care Pharmacother; 2022 Mar; 36(1):2-10. PubMed ID: 35254209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with opioid-tapering success: A mixed methods study.
    Kuntz JL; Dickerson JF; Schneider JL; Firemark AJ; Papajorgji-Taylor D; Slaughter M; Reese KR; Thorsness LA; Sullivan MD; Debar LL; Smith DH
    J Am Pharm Assoc (2003); 2021; 61(3):248-257.e1. PubMed ID: 33485815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Those Conversations in My Experience Don't Go Well": A Qualitative Study of Primary Care Provider Experiences Tapering Long-term Opioid Medications.
    Kennedy LC; Binswanger IA; Mueller SR; Levy C; Matlock DD; Calcaterra SL; Koester S; Frank JW
    Pain Med; 2018 Nov; 19(11):2201-2211. PubMed ID: 29126138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patients' Experience With Opioid Tapering: A Conceptual Model With Recommendations for Clinicians.
    Henry SG; Paterniti DA; Feng B; Iosif AM; Kravitz RL; Weinberg G; Cowan P; Verba S
    J Pain; 2019 Feb; 20(2):181-191. PubMed ID: 30243859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A physician-pharmacist collaborative care model to prevent opioid misuse.
    Lagisetty P; Smith A; Antoku D; Winter S; Smith M; Jannausch M; Mi Choe H; Bohnert ASB; Heisler M
    Am J Health Syst Pharm; 2020 May; 77(10):771-780. PubMed ID: 32315401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient Perspectives on Improving Patient-Provider Relationships and Provider Communication During Opioid Tapering.
    Kosakowski S; Benintendi A; Lagisetty P; Larochelle MR; Bohnert ASB; Bazzi AR
    J Gen Intern Med; 2022 May; 37(7):1722-1728. PubMed ID: 34993861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary care provider perceptions of an integrated community pharmacy hypertension management program.
    Vordenberg SE; Thompson AN; Vereecke A; Smrke R; Serlin DC; Fan AL; Choe HM
    J Am Pharm Assoc (2003); 2021; 61(3):e107-e113. PubMed ID: 33353833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation of a pharmacist-managed clinic for patients with chronic nonmalignant pain.
    Norman JL; Kroehl ME; Lam HM; Lewis CL; Mitchell CN; O'Bryant CL; Trinkley KE
    Am J Health Syst Pharm; 2017 Aug; 74(16):1229-1235. PubMed ID: 28790075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical Record Documentation About Opioid Tapering: Examining Benefit-to-Harm Framework and Patient Engagement.
    Buonora M; Perez HR; Stumph J; Allen R; Nahvi S; Cunningham CO; Merlin JS; Starrels JL
    Pain Med; 2020 Oct; 21(10):2574-2582. PubMed ID: 32142143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk assessment and counseling behaviors of healthcare professionals managing patients with chronic pain: a national multifaceted assessment of physicians, pharmacists, and their patients.
    Salinas GD; Susalka D; Burton BS; Roepke N; Evanyo K; Biondi D; Nicholson S
    J Opioid Manag; 2012; 8(5):273-84. PubMed ID: 23247904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient Perspectives on Mental Health and Pain Management Support Needed Versus Received During Opioid Deprescribing.
    Yarborough BJH; Stumbo SP; Schneider JL; Ahmedani BK; Daida YG; Hooker SA; Lapham GT; Negriff S; Rossom RC
    J Pain; 2024 Jul; 25(7):104485. PubMed ID: 38311195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuation of opioid replacement program delivery in the aftermath of cyclones in Queensland, Australia: A qualitative exploration of the perspectives of pharmacists and opioid replacement therapy staff.
    O'Dwyer N; Cliffe H; Watson KE; McCourt E; Singleton JA
    Res Social Adm Pharm; 2020 Aug; 16(8):1081-1086. PubMed ID: 31753692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of outcomes following high-dose opioid tapering in a Veterans Healthcare System.
    Hundley L; Spradley S; Donelenko S
    J Opioid Manag; 2018; 14(2):89-101. PubMed ID: 29733095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients' Perspectives on Tapering of Chronic Opioid Therapy: A Qualitative Study.
    Frank JW; Levy C; Matlock DD; Calcaterra SL; Mueller SR; Koester S; Binswanger IA
    Pain Med; 2016 Oct; 17(10):1838-1847. PubMed ID: 27207301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.